Skip to content

Clinical trials

Glucose Metabolism Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Country / region: United States Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20042
20068
20076
20087
20095
20107
20114
20122
20132
20142
20152
20167
20178
201812
20197
20208
20216
20227
20236
20249
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85
Recruiting14
Terminated11
Active, not recruiting10
Unknown status6
Withdrawn2
Suspended2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda20
Eli Lilly and Company7
Pfizer7
AstraZeneca6
Ultragenyx Pharmaceutical Inc5
Albert Einstein College of Medicine4
University of Missouri-Columbia4
Washington University School of Medicine4
Jaeb Center for Health Research3
Fractyl Health Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders131
Diabetes Mellitus76
Diabetes Mellitus, Type 263
Metabolic Diseases52
Endocrine System Diseases45
Dyslipidemias18
Insulin Resistance13
Obesity11
Diabetes Mellitus, Lipoatrophic10
Autoimmune Diseases8

Trials

Showing 76 to 100 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.